Target intelligence / Profile preview

Eukaryotic translation termination factor 1 pseudogene 2 (ETF1P2)

Target
ETF1P2
Molecular classification
Pseudogene
01

Overview

Eukaryotic translation termination factor 1 pseudogene 2 (ETF1P2) is a non-coding, processed pseudogene derived from the *ETF1* gene, which encodes a class-1 polypeptide chain release factor important for translation termination. Pseudogenes like ETF1P2 may be transcribed in some contexts but do not encode active proteins, lack canonical promoter and regulatory elements, and are generally considered non-functional genomic fossils. There are no established roles for ETF1P2 in human biology or disease, nor is it considered a drug target or therapeutic/receptor molecule[1][3]. Critical notes: - ETF1P2 should not be confused with *ETF1* (the protein-coding gene encoding eukaryotic translation termination factor 1), which does have known functions in translation termination and RNA surveillance processes[2]. - The inclusion of ETF1P2 as a target in therapeutic databases is incorrect due to its pseudogene status[1]. - No interacting drugs, mechanisms of action, or known biomarker or disease utility are associated with ETF1P2[1].

Beyond the preview

Go deeper on Eukaryotic translation termination factor 1 pseudogene 2 (ETF1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation termination factor 1 pseudogene 2 (ETF1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call